Radiant Lotus Health

Soft launch in April

https://www.urologytimes.com/view/fda-approves-label-changes-for-first-batch-of-menopausal-hormone-therapy-products

FDA approves label changes for first batch of menopausal hormone therapy products | Urology Times FDA lifts boxed warnings on 6 menopausal hormone therapies following a review of the evidence on risks and benefits.

To my dearest, beautiful friends and clients:

We are closing Status Allergy and Status Medical Aesthetics at the end of February. As most of you know, I (Neesha) lost my incredible mother at the end of August of 2023. She was the cofounder of Status Allergy, the rock of the family, and the inspiration for my aesthetics business. My father and supervising physician, Dr. Shah, is 85. Accordingly, we have decided to close this chapter and move on to the next one.

I will do one last hurrah of botox/xeomin for those who need prior to the end of February. I will also continue to offer the weight loss medications Tirzepatide and Semaglutide until the end of February.

Dates for the botox and xeomin will be announced soon. I'll probably do one Thursday and one Saturday.

Thank you to all of you. It has been my pleasure and honor working with you.

https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management

FDA Approves New Medication for Chronic Weight Management The FDA approved Zepbound (tirzepatide) for chronic weight management in adults with obesity or are overweight.